PATENT CLAIM ANALYSIS

Application Number: 15741981
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["424", "187100"]

Abstract:
Creation of HIV-1 vaccine immunogens based on glycopeptide scaffolds containing sequences from the V1/V2/V3 and C3 domains of HIV-1 gp120 that is able to bind multiple broadly neutralizing antibodies when expressed in mammalian cells that incorporate mannose-5 and mannose-9 glycans.

Claim (Index 1):
A vaccine immunogen comprising of sequences derived from fusion of the V1/V2 and V3/C3 domain of the HIV-1 envelope protein gp120.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.10811
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15635064', '14427393', '15695753', '14363131', '14784501']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7229808601585601
- 35 USC 102 Novelty (BERT): 0.6095663264164295
- Combined Prediction Score: 0.7116394067843471
- Mean Citation Score: 433.10390000000007
- Max Citation Score: 579.71185
- Similarity Product: 462.2551789452912

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test